Inhaled Insulin Approved

A Food and Drug Administration panel recommended approving the first inhaled form of insulin (Exubera).

They’re giving it the go-ahead despite questions about what how it might affect people with lung disease or those exposed to secondhand smoke. That makes me a bit nervous, because those and other concerns exist, too.

However, in theory, studies on long-term effects of Exubera are proposed to go until 2019, Yahoo reports.

"We understand the need to assess the long-term effects on pulmonary function," Dr. Neville Jackson of Pfizer told the press.

Well, that sounds promising — at at least they’re looking into it further to find out about more side effects.

Frankly, I’m always puzzled by stories that purport to help people with diabetes — and yet, you find NO mention of the role the patient plays in all of this!

Seriously, I’ve heard of many remarkable stories and even medical studies from Harvard and other institutions, where folks with diabetes have been able to reverse their health situation — or mimimize the extent of their diabetes. Of course, not everyone can do this, but it’s worth talking about over and over again — and encouraging people to change their lifestyle (get off their butts and exercise) and change their diet (quit or at least cut back on those quickie carbs).

Special thanks to The Diabetes Blog for alerting me to this story. If you haven’t seen this site yet, check it out. They run some really interesting information of interest to diabetics.